Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
about
Salinomycin as a drug for targeting human cancer stem cellsPI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical applicationTumor and stromal-based contributions to head and neck squamous cell carcinoma invasionSalinomycin: a novel anti-cancer agent with known anti-coccidial activitiesSalinomycin induces autophagy in colon and breast cancer cells with concomitant generation of reactive oxygen speciesInhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell linesInhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cellsMinigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.Sensitization of cancer cells through reduction of total Akt and downregulation of salinomycin-induced pAkt, pGSk3β, pTSC2, and p4EBP1 by cotreatment with MK-2206.Cancerous stem cells: deviant stem cells with cancer-causing misbehavior.Impact of Salinomycin on human cholangiocarcinoma: induction of apoptosis and impairment of tumor cell proliferation in vitroSalinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and AktTargeting breast cancer stem cells.Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.Salinomycin inhibited cell proliferation and induced apoptosis in human uterine leiomyoma cells.Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 proteinSalinomycin Suppresses PDGFRβ, MYC, and Notch Signaling in Human Medulloblastoma.Cancer stem cells and side population cells in breast cancer and metastasis.Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasisSalinomycin and other polyether ionophores are a new class of antiscarring agentSalinomycin inhibits the tumor growth of glioma stem cells by selectively suppressing glioma-initiating cells.A switch from CD44⁺ cell to EMT cell drives the metastasis of prostate cancerMaduramicin inhibits proliferation and induces apoptosis in myoblast cellsSalinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasisLower salinomycin concentration increases apoptotic detachment in high-density cancer cells.The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell linesInhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenanceSalinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.Wnt modulating agents inhibit human cytomegalovirus replication.Breast cancer stem cells.Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy.Low amount of salinomycin greatly increases Akt activation, but reduces activated p70S6K levelsCancer stem cell drugs target K-ras signaling in a stemness context.Low-dose salinomycin induces anti-leukemic responses in AML and MLL.Breast cancer stem cells: treatment resistance and therapeutic opportunities.The role of colorectal cancer stem cells in metastatic disease and therapeutic response
P2860
Q21285139-68037FD8-DF7C-4E57-A550-4F3D3A6F3C99Q26801538-C704DB88-3730-455A-9CAD-46ED0B209DADQ26825164-F25026C9-D899-4C14-9699-01DDB17488F0Q26853644-CBDE8A2C-9078-455E-83CC-3E8ECDFE244DQ28483896-1793C2B7-98BB-49EB-BB4E-27A62F1B39BFQ28534136-582C3010-DD04-47A0-A6A2-2B4217E0948BQ28537942-DD8C6C19-66DA-42A8-83E2-805401FE77F1Q28538669-BD588E02-4BB5-4014-84D4-AD83C6702A86Q33962901-CBD0B0E6-C0D5-4315-981C-B59D8FB03A26Q33992871-CF649610-07B8-4BFF-8F5B-27F4C0FD13FAQ33999466-7E98735B-7FF7-44BD-A79E-AA296A2B9155Q34443640-8F17052B-38EA-4CB5-92B4-19457F5F4EB7Q34486971-24FF9195-3F7D-4868-ADA1-D351F59357BBQ34505105-90E36AF0-6BF1-4A91-A711-CAA3AE596243Q34531550-0626AECA-A2AA-4E7F-9318-DB8791E671CCQ34577035-D843BFA5-C2F0-4C39-A176-D4196FAB4BCDQ34583585-5D46A3C6-A1EB-4BA8-8BF5-6BAEA55ED69EQ34610115-8BBEEB7A-958E-4AB4-831E-31BB7408B44CQ35038054-29055AD1-6537-400D-81DA-5E6C3185C1A2Q35053270-45DE62DD-3131-40B3-BC11-DA1A6F91B3D8Q35055573-3E3B5814-7703-47C6-9254-0D9134DA7D9DQ35111314-0C21112B-2F05-4D7F-93D8-86333649EC5DQ35176048-B74E6531-FA32-411C-A5E9-028601DF2740Q35532104-93D2ADFF-9F5E-432A-BD96-8C5FC6517B28Q35653860-CDF3D0D0-1D82-4DA6-807A-152DDE24B50DQ35975423-52F23256-C0E1-4B54-9388-4E0F0FA58806Q35983858-5D1A5146-F08D-42A5-BC46-07BA931D2E3AQ36327392-2A5334B1-3001-4BF7-8F45-599EA2937697Q36396532-842104E4-02C1-48C0-9BBE-43EED134C17AQ36742179-D2829AE9-3C90-4C63-865E-D85F3C77696BQ36892078-C783C447-65AD-4DE0-A118-135FFD5F1A99Q36985137-1333D9A6-72C2-4A47-B7A3-216E7589839EQ37026623-E01BEADE-775A-4C0B-9AEE-DF1B2F466BBDQ37121784-464DF84F-DC24-4613-9961-949CAFE95C48Q37158877-A2BF952F-42F7-4987-8E32-E62766912498Q37225029-C115C0C1-AA41-4248-90BE-56A0BFAC75A4Q37325194-ABFE70E6-C44B-400A-8E09-B12D0B239E87Q37687407-EF766110-2115-4466-9394-D8F5E3C222A3Q37839530-C37CDA33-7CE7-41F7-8B1F-6416781396EAQ37841141-C6AA4FCC-70DF-481C-8ACD-79F090A4BE55
P2860
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@ast
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@en
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@nl
type
label
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@ast
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@en
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@nl
prefLabel
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@ast
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@en
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@nl
P2093
P1476
Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
@en
P2093
Andreas Heinold
Cord Naujokat
Dominik Fuchs
Volker Daniel
P304
P356
10.1016/J.BBRC.2009.10.042
P407
P577
2009-10-14T00:00:00Z